Furthermore, XPO1 has been identified to be involved in the regulation of several neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal dementia (Archbold et al., 2018; Ederle et al., 2018; Steyaert et al., 2018). This evidence concerns the gene XPO1 and frontotemporal dementia.